| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 4or | PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide | 4zjj | 93.09 |
| 2 | 4oq | PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine | 4zji | 91.75 |
| 3 | 6bz | Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9 | 5ime | 88.43 |
| 4 | 2ol | Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors | 4o0t | 86.43 |
| 5 | 4pv | Serine/threonine-protein kinase PAK1 complexed with a dibenzodiazepine: identification of an allosteric site on PAK1 | 4zlo | 85.92 |
| 6 | 4t5 | Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17 | 4zy5 | 81.28 |
| 7 | 59t | Crystal structure of PAK1 in complex with an inhibitor compound G-5555 | 5dey | 80.68 |
| 8 | 59n | Crystal structure of PAK1 in complex with an inhibitor compound 5 | 5dew | 80.39 |
| 9 | 7kc | Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors | 4o0r | 79.94 |
| 10 | ipv | Pak1 in complex with bis-anilino pyrimidine inhibitor | 5kbq | 79.35 |
| 11 | xr1 | Crystal structure of PAK1 kinase domain in complex with FRAX597 inhibitor | 4eqc | 78.96 |
| 12 | 4t6 | Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29 | 4zy6 | 78.62 |
| 13 | 59u | Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036 | 5dfp | 78.59 |
| 14 | ipw | Pak1 in complex with 7-azaindole inhibitor | 5kbr | 77.6 |
| 15 | c7y | P21-activated kinase 1 in complex with a 4-azaindole inhibitor | 6b16 | 76.72 |
| 16 | 4t3 | Crystal structure of P21 activated kinase 1 in complex with an inhibitor compound 4 | 4zy4 | 74.21 |
| 17 | 2k0 | Crystal structure of the kinase domain of human PAK1 in complex with compound 15 | 4p90 | 73.32 |